Revenue | ₹448.27Cr |
Net Profits | ₹30.85Cr |
Net Profit Margins | 6.88% |
Astrazeneca Pharma India Ltd’s revenue jumped 42.1% since last year same period to ₹448.27Cr in the Q3 2024-2025. On a quarterly growth basis, Astrazeneca Pharma India Ltd has generated 7.72% jump in its revenue since last 3-months.
Astrazeneca Pharma India Ltd’s net profit jumped 95.25% since last year same period to ₹30.85Cr in the Q3 2024-2025. On a quarterly growth basis, Astrazeneca Pharma India Ltd has generated -19.72% fall in its net profits since last 3-months.
Astrazeneca Pharma India Ltd’s net profit margin jumped 37.4% since last year same period to 6.88% in the Q3 2024-2025. On a quarterly growth basis, Astrazeneca Pharma India Ltd has generated -25.48% fall in its net profit margins since last 3-months.
The revenue for Astrazeneca Pharma India Ltd in the Q3 results 2024 was ₹448.27Cr.
The net profit for Astrazeneca Pharma India Ltd in the Q3 results 2024 was ₹30.85Cr.
The net profit margin for Astrazeneca Pharma India Ltd in the Q3 results 2024 was 6.88%.
The revenue for Astrazeneca Pharma India Ltd in the Q3 results 2023 was ₹315.45Cr.
The net profit for Astrazeneca Pharma India Ltd in the Q3 results 2023 was ₹15.80Cr.
The net profit margin for Astrazeneca Pharma India Ltd in the Q3 results 2023 was 5.01%.